Gts Securities LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $2.99 Million - $3.29 Million	-6,500 Reduced 31.55%	14,100 $6.56 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $1.22 Million - $1.51 Million	-3,100 Reduced 13.08%	20,600 $9.66 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $1.35 Million - $1.47 Million	-3,300 Reduced 12.22%	23,700 $9.91 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $754,600 - $903,496	2,200 Added 8.87%	27,000 $11 Million
Q3 2023 Nov 15, 2023	BUY	$338.18 - $362.46 $8.39 Million - $8.99 Million	24,800 New	24,800 $8.62 Million

1,722

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.